Company Profile: Medtronic plc (MDT)
MDT insider trades (13 months) →$98.88 −0.41% vs. previous close · Market cap $126.48B
Today's multi-factor rank: 295 of 461 · see the ranking
Market and Valuation
Price & Market
52-Week Range
Volume
Valuation Multiples
Diluted EPS for the last 12 months: the four quarters ended Jul 31, 2026, from the accounts filed with the SEC on Sep 3, 2026. The P/E is the price divided by that EPS.
Dividends
Valuation Context
P/E vs sector (indicative)
Loading historical OHLCV database...
Financial Statements TTM (Trailing 12 Months)
Income Statement
Margins
Per Share
Diluted EPS for the last 12 months: the four quarters ended Jul 31, 2026, from the accounts filed with the SEC on Sep 3, 2026. The P/E is the price divided by that EPS.
Balance Sheet & Liquidity
Cash Flows
Profitability
Historical Evolution (Last 4 Years)
Income Statement
Balance Sheet
Cash Flow
EPS and Earnings Per Share
Key EPS Metrics
Diluted EPS for the last 12 months: the four quarters ended Jul 31, 2026, from the accounts filed with the SEC on Sep 3, 2026. The P/E is the price divided by that EPS.
Growth and Margins
Per Share
Cash Flows (TTM)
EPS Surprise History - Last 4 Quarters
Actual vs. Analyst Estimates · Green = beat expectations · Red = missed
| Quarter | Period | Actual EPS | Estimated EPS | Difference | Surprise % | Currency |
|---|
Ownership Structure
Ownership Distribution
Shares & Short Interest
Governance Score (1=Best, 10=Worst)
Top Institutional Holders
Position Change: ▲ Increased · ▼ Reduced · = Unchanged
| Organization | Report Date | % Shares | No. Shares | Value (USD) | Change % |
|---|
Top Mutual Funds
Position Change: ▲ Increased ▼ Decreased = Unchanged
| Fund | Report Date | % Shares | No. Shares | Value (USD) | Change % |
|---|
Recent Insider Trades
| Executive / Insider | Title | Date | Action | Shares |
|---|
Options Chain
CALLS
| Strike | Last | Bid | Ask | Vol. | O.I. | IV |
|---|
PUTS
| Strike | Last | Bid | Ask | Vol. | O.I. | IV |
|---|
Medtronic plc (MDT) SEC filings: 10-K, 10-Q and 8-K
Direct links to financial reports filed with the SEC.
| Type | Date | Official link |
|---|---|---|
| 11-K | 2026-10-21 | View filing ↗ |
| 8-K | 2026-10-19 | View filing ↗ |
| SC TO-I/A | 2026-10-14 | View filing ↗ |
| SC TO-I/A | 2026-10-13 | View filing ↗ |
| 425 | 2026-10-09 | View filing ↗ |
| 425 | 2026-10-08 | View filing ↗ |
| 425 | 2026-10-07 | View filing ↗ |
| 425 | 2026-10-06 | View filing ↗ |
| 425 | 2026-10-05 | View filing ↗ |
| 425 | 2026-10-02 | View filing ↗ |
Company and Executive Profile
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
General Information
Key Executives
| Name | Title | Age | Total pay |
|---|---|---|---|
| Mr. Geoffrey Straub Martha | Chairman of the Board & CEO | 55 | 4.09M |
| Mr. Michael Marinaro | President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops | 54 | 1.92M |
| Mr. Thierry Pieton | Executive VP & CFO | 55 | 4.22M |
| Ms. Michelle Quinn | Executive VP, General Counsel & Secretary | 56 | 2.49M |
| Mr. Rogerio Branco | SVP & Chief Operations and Supply Chain Officer | - | - |
| Ms. Denise L. Blomquist | VP, Global Controller & Chief Accounting Officer | - | - |
| Dr. Laura Mauri M.D., M.Sc. | Senior VP and Chief Scientific & Medical Officer | 55 | - |
| Ms. Ingrid Goldberg | Vice President & Head of Investor Relations | - | - |
You have seen the engine room
A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.